Press Release Adlai Nortye Announces First Patient Dosed in Intermittent Weekly Dosing Arm of Global Phase 1 Trial of Pan-RAS(ON) Inhibitor AN9025 Jul 16
Press Release Adlai Nortye Expands Scientific Advisory Board with Appointment of Two Leading Medical Oncologists Jul 13